Skip to content
Metabolic HealthMitochondria

SANA (MVD1): using creatine turnover to increase energy demand

A salicylate-derived small molecule explores creatine-dependent thermogenesis: increase ATP demand in adipose tissue, then study how fuel oxidation responds.

Evidence type
Preclinical creatine-pathway work + early human safety/PK
Provenance
Adapted from RUO
Status
Published 1 November 2026

Adapted with permission from the owner’s reviewed RUO source material. Members-only references are linked below; public research citations support the scientific context.

Energy expenditure through a different route

SANA is a nitroalkene derivative of salicylate, and the published study explicitly identifies MVD1 as its clinical-development name. It is a small molecule rather than a peptide. Its research appeal is a route to energy expenditure centered on creatine metabolism in adipose tissue—not an appetite-suppression mechanism.

Creatine and phosphocreatine help transfer high-energy phosphate groups. In a thermogenic cycle, repeated turnover can increase ATP demand without storing all that energy as useful work. Cells must then regenerate ATP, potentially increasing fuel oxidation and releasing more of the energy as heat. The RUO post and course use this sequence to connect a cellular process with a whole-body metabolic hypothesis.

Creatine-linked does not mean direct UCP1 uncoupling

UCP1 is a mitochondrial protein that can dissipate a proton gradient as heat instead of coupling all of it to ATP production. The SANA findings describe a different experimental route: creatine-dependent energy expenditure with increased mitochondrial respiration. The paper reported effects independent of UCP1 and AMPK activity in the tested models.

Creatine depletion disrupted the response, and experiments involving Ckmt1, which encodes mitochondrial creatine kinase, supported a role for creatine-linked biology. That implicates a pathway; it does not establish CKMT1 as a proven direct binding target of SANA. This distinction keeps the explanation stronger than a generic “mitochondrial uncoupler” label.

From metabolic possibility to human testing

The same publication reports a first-in-human phase 1A/B trial. Safety and tolerability were the primary endpoint; pharmacokinetic and exploratory metabolic measures added early information about exposure and response. Short-term body-weight and metabolic observations are reasons for further testing, not proof of lasting weight-loss effectiveness.

The promising idea is that energy expenditure may be influenced through regulated intracellular turnover rather than only through food intake. This single teaser combines the owner-reviewed SANA post and course context, with both members-only references below. The full primary paper supplies the independently checked identity and mechanistic detail.

KeywordsMVD1 · nitroalkene · salicylate · creatine · thermogenesis · CKMT1 · phosphocreatine

Public research & references

  1. [1]A nitroalkene derivative of salicylate, SANA, induces creatine-dependent thermogenesis and promotes weight loss (2025). Nature Metabolism. DOI: 10.1038/s42255-025-01311-z (opens in a new tab)

Research education, not individualized medical advice.